Patents Assigned to Alpha Synergy Development, Inc.
  • Compositions and methods for reversing rebound hyperemia
    Patent number: 8338421
    Abstract: The invention generally relates to compositions and methods for inducing vasoconstriction with low incidence of rebound hyperemia. The compositions comprise highly selective alpha-2 adrenergic receptor agonists, at low concentrations, such as below 0.05% weight by volume. The compositions preferably comprise brimonidine. The compositions preferably have pH between about 5.5 and about 6.5.
    Type: Grant
    Filed: July 27, 2009
    Date of Patent: December 25, 2012
    Assignee: Alpha Synergy Development, Inc.
    Inventor: Gerald Horn
  • COMPOSITIONS AND METHODS FOR TREATMENT OF GLAUCOMA
    Publication number: 20120309804
    Abstract: The invention provides ?-2 adrenergic receptor agonist compositions and methods for treating glaucoma and other intraocular conditions. The preferred ?-2 agonist used in the inventive compositions and methods is dexmedetomidine.
    Type: Application
    Filed: August 14, 2012
    Publication date: December 6, 2012
    Applicant: Alpha Synergy Development Inc.
    Inventor: Gerald Horn
  • COMPOSITIONS AND METHODS FOR TREATMENT OF GLAUCOMA
    Publication number: 20120309720
    Abstract: The invention provides ?-2 adrenergic receptor agonist compositions and methods for treating glaucoma and other intraocular conditions. The preferred ?-2 agonist used in the inventive compositions and methods is dexmedetomidine.
    Type: Application
    Filed: August 14, 2012
    Publication date: December 6, 2012
    Applicant: Alpha Synergy Development Inc.
    Inventor: Gerald Horn
  • Preferential vasoconstriction compositions and methods of use
    Patent number: 8293742
    Abstract: The invention generally relates to compositions and methods for preferential vasoconstriction of smaller blood vessels relative to larger blood vessels. The compositions comprise highly selective alpha-2 adrenergic receptor agonists, at low concentrations, such as below 0.05% weight by volume. The compositions preferably comprise brimonidine. The compositions preferably have pH between about 5.5 and about 6.5.
    Type: Grant
    Filed: July 27, 2009
    Date of Patent: October 23, 2012
    Assignee: Alpha Synergy Development, Inc.
    Inventor: Gerald Horn
  • Compositions and methods for reducing capillary permeability
    Patent number: 8283350
    Abstract: The invention generally relates to compositions and methods for reducing capillary permeability. The compositions comprise highly selective alpha-2 adrenergic receptor agonists, at low concentrations, such as below 0.05% weight by volume. The compositions preferably comprise brimonidine. The compositions preferably have pH between about 5.5 and about 6.5.
    Type: Grant
    Filed: July 27, 2009
    Date of Patent: October 9, 2012
    Assignee: Alpha Synergy Development, Inc.
    Inventor: Gerald Horn
  • Anesthetic compositions and methods of use
    Patent number: 8080550
    Abstract: The invention generally relates to anesthetic compositions comprising low doses of a selective a-2 adrenergic receptor agonists in combination with anesthetic agents. The invention also relates to methods of using these compositions; in particular, the use of these compositions in humans to enhance the efficacy of a local peripheral anesthetic injection. The compositions and the methods are particularly useful in regional block anesthetic injections, and more particularly, in dental anesthetic injections.
    Type: Grant
    Filed: July 27, 2009
    Date of Patent: December 20, 2011
    Assignee: Alpha Synergy Development, Inc.
    Inventor: Gerald Horn